Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs

Paramyxovirus vaccine vectors based on human parainfluenza virus type 3 (HPIV-3) and Newcastle disease virus (NDV) have been previously evaluated against Ebola virus (EBOV) challenge. Although both the viral vectored vaccines efficiently induce protective immunity, some concerns remain to be solved....

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Asuka, Kim, Shin-Hee, Manoharan, Vinoth K., Varghese, Berin P., Paldurai, Anandan, Samal, Siba K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445115/
https://www.ncbi.nlm.nih.gov/pubmed/30940854
http://dx.doi.org/10.1038/s41598-019-42004-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445115/
https://www.ncbi.nlm.nih.gov/pubmed/30940854
http://dx.doi.org/10.1038/s41598-019-42004-4

Ejemplares similares